Life sciences

Life sciences

Straightforward, business-friendly advice from lawyers who understand the unique challenges and opportunities presented by the life sciences sector.  We enjoy spending time getting to know our clients and working alongside them for the long term. Visit our life sciences hub. 
  • Profile
  • Key contacts

We work with a wide range of clients from the life sciences sector including:

  • pharmaceutical companies
  • biotechnology companies
  • medical device and diagnostic companies
  • manufacturers, distributors and logistics companies
  • investors
  • banks and financial institutions. 

"Every single person is excellent. Superb knowledge of the sector and relevant people. Always produce a great job."

The Legal 500 UK 2023

Lawyer

Dan Holland Partner

T:  +44 20 7809 2108
M:  +44 7841 923 656 Email Dan | Vcard Office:  London

Lawyer

Rob Jacob Partner

T:  +44 20 7809 2072
M:  +44 7825 601 925 Email Rob | Vcard Office:  London

Lawyer

Naomi Leach Partner

T:  +44 20 7809 2960
M:  +44 7769 143 367 Email Naomi | Vcard Office:  London

Lawyer

Tom Page Partner

T:  +44 20 7809 2021
M:  +44 7813 600 516 Email Tom | Vcard Office:  London

Lawyer

Alexandra Pygall Partner

T:  +44 20 7809 2137
M:  +44 7881 314 566 Email Alexandra | Vcard Office:  London

Lawyer

Kristian Shearsby Partner

T:  +44 20 7809 2813
M:  +44 7880 488 532 Email Kristian | Vcard Office:  London

Latest news & insights

20 Nov 2023

From News

Stephenson Harwood advises on $25 million funding in ViaNautis Bio

Stephenson Harwood LLP has advised UCB Ventures, BGF and 4Bio Capital, who led the over-subscribed Series A funding round of $25million in ViaNautis Bio.

More

13 Oct 2023

From News

Stephenson Harwood advises DMS Group on SFT Acquisition

Law firm Stephenson Harwood LLP has advised DMS Group, a Euronext Growth Paris listed company, on its acquisition of Solutions For Tomorrow (SFT).

More

20 Sep 2023

From News

Stephenson Harwood advises BenevolentAI on strategic collaboration with Merck

Law firm Stephenson Harwood LLP has advised BenevolentAI on its recent strategic collaboration with Merck.

More

13 Sep 2023

From News

Stephenson Harwood advises Novacyt on Yourgene Health takeover

Law firm Stephenson Harwood LLP has advised long-standing diagnostics client Novacyt S.A. in relation to its recommended takeover of Yourgene Health plc

More

05 Sep 2023

From News

Stephenson Harwood advises Flarin on fundraise

Law firm Stephenson Harwood LLP has advised Flarin, the joint pain relief brand, on its fundraise through existing investor IW Capital and through ITV's Media for Equi..

More

01 Aug 2023

From Insights

Life sciences A to Z - J is for jumping the gun

Illumina pays record fine for pre-emptive GRAIL merger completion

More

12 Jul 2023

From Insights

Life sciences A to Z - I is for investment allocation

On the evening of Monday 10 July the Rt Hon Jeremy Hunt delivered his first Mansion House speech as the UK Chancellor of the Exchequer. A key element of the speech was..

More

15 May 2023

From News

Stephenson Harwood advises Bicycle Therapeutics on radiotherapy deal with Bayer

Law firm Stephenson Harwood LLP has advised Bicycle Therapeutics plc on its recent strategic collaboration agreement with Bayer to discover and develop Bicycle radioco..

More

11 Apr 2023

From Insights

Time to reap the benefits? The UK's new subsidy control regime comes into effect

On 4 January 2023, the UK's new post-Brexit subsidy control regime officially came into force, in the form of the Subsidy Control Act 2022 ("SCA").

More

30 Mar 2023

From News

Stephenson Harwood advises Bicycle Therapeutics on radiopharmaceuticals deal with Novartis

Law firm Stephenson Harwood LLP has advised Bicycle Therapeutics on its recent strategic collaboration agreement with Novartis to discover and develop multiple targete..

More

24 Mar 2023

From Insights

Life sciences podcast

The Stephenson Harwood life sciences podcast provides an overview of key legal developments relating to the sector.

More

13 Mar 2023

From News

Stephenson Harwood's response to recent news regarding Silicon Valley Bank

Having spent the weekend supporting clients reacting to the bank's potential collapse in the UK, Stephenson Harwood is pleased to hear the latest news this morning con..

More

09 Mar 2023

From Insights

Take two: What's new in the Latest UK Data Protection and Digital Information Bill?

After a rather stop start journey, a new Data Protection and Digital Information (No. 2) Bill was introduced to Parliament on 8 March 2023 by the Department for Scienc..

More

23 Jan 2023

From Insights

Life sciences A to Z - H is for hungry capital companies - life sciences businesses and the new Pre-Emption Group Principles

The Financial Reporting Council ("FRC") has issued a new Statement of Principles (the "Principles") on behalf of the Pre-Emption Group ("PEG") which apply to listed co..

More

12 Dec 2022

From Insights

Changes to UK R&D SME tax credits

Among the changes announced in the Chancellor's Autumn Statement on 17 November 2022 were significant and largely unfavourable proposed changes to the UK Research and ..

More

02 Nov 2022

From Insights

Under the antitrust spotlight: patent litigation

In this briefing, we explore the latest developments in the European domain of alleged patent litigation abuses.

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.